Imbruvica Market Insights Video

According to Cognitive Market Research, the global Imbruvica market size is USD 9698.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 24.30% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 3879.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 22.5% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 2909.46 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 2230.59 million in 2024 and will grow at a compound annual growth rate (CAGR) of 26.3% from 2024 to 2031.
• Latin America had a market share for more than 5% of the global revenue with a market size of USD 484.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 23.7% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 193.96 million in 2024 and will grow at a compound annual growth rate (CAGR) of 24.0% from 2024 to 2031.
• The Chronic Lymphocytic Leukemia held the highest Imbruvica market revenue share in 2024.